FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018093166> ?p ?o ?g. }

• W2018093166 endingPage "1232" @default.
• W2018093166 startingPage "1221" @default.
• W2018093166 abstract "Hypoxia and hypoxia-inducible factor-1 (HIF-1) play a critical role in glioblastoma multiforme (GBMs). CXCR4 is involved in angiogenesis and is upregulated by HIF-1alpha. CXCR4 is a chemokine receptor for stromal cell-derived factor-1 (SDF-1)alpha, also known as CXCL12. We hypothesized that CXCR4 would be upregulated by hypoxia in GBMs. First, we investigated the expression of HIF-1alpha and CXCR4 in GBMs. CXCR4 was consistently found colocalized with HIF-1alpha expression in pseudopalisading glioma cells around areas of necrosis. In addition, angiogenic tumor vessels were strongly positive for CXCR4. Next, we tested the in vitro effect of hypoxia and vascular endothelial growth factor (VEGF) on the expression of CXCR4 in glioma cell lines and in human brain microvascular endothelial cells (HBMECs). Exposure to hypoxia induced significant expression of CXCR4 and HIF-1alpha in glioma cells, whereas treatment with exogenous VEGF increased CXCR4 expression in HBMECs. We also transfected U87MG glioma cells with an HIF-1alpha construct and observed that CXCR4 was upregulated in these cells even in normoxic conditions. We then used a lentivirus-mediated shRNA expression vector directed against HIF-1alpha. When exposed to hypoxia, infected cells failed to show HIF-1alpha and CXCR4 upregulation. We performed migration assays under normoxic and hypoxic conditions in the presence or absence of AMD3100, a CXCR4 inhibitor. There was a significant increase in the migration of U87MG and LN308 glioma cells in hypoxic conditions, which was inhibited in the presence of AMD3100. These studies demonstrate the critical role played by hypoxia and CXCR4 in glioma cell migration. Based on these studies, we suggest that hypoxia regulates CXCR4 in GBMs at two levels. First, through HIF-1alpha in the pseudopalisading tumor cells themselves and, secondly, by the VEGF-stimulated angiogenic response in HBMECs. We believe this knowledge may lead to a potentially important two-pronged therapy against GBM progression using chemotherapy targeting CXCR4." @default.
• W2018093166 created "2016-06-24" @default.
• W2018093166 creator A5002545881 @default.
• W2018093166 creator A5003459453 @default.
• W2018093166 creator A5015059017 @default.
• W2018093166 creator A5029653810 @default.
• W2018093166 creator A5046740518 @default.
• W2018093166 creator A5060455569 @default.
• W2018093166 creator A5079838143 @default.
• W2018093166 creator A5082035709 @default.
• W2018093166 creator A5084386513 @default.
• W2018093166 date "2006-12-01" @default.
• W2018093166 modified "2023-10-17" @default.
• W2018093166 title "Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion" @default.
• W2018093166 cites W1480185538 @default.
• W2018093166 cites W1501974099 @default.
• W2018093166 cites W1536266814 @default.
• W2018093166 cites W1575688729 @default.
• W2018093166 cites W1578283200 @default.
• W2018093166 cites W1628907781 @default.
• W2018093166 cites W1830307401 @default.
• W2018093166 cites W1963984954 @default.
• W2018093166 cites W1965463107 @default.
• W2018093166 cites W1965621019 @default.
• W2018093166 cites W1967980459 @default.
• W2018093166 cites W1980475208 @default.
• W2018093166 cites W1982861439 @default.
• W2018093166 cites W1984401435 @default.
• W2018093166 cites W1996679013 @default.
• W2018093166 cites W1996830477 @default.
• W2018093166 cites W1999641808 @default.
• W2018093166 cites W2002355614 @default.
• W2018093166 cites W2002403202 @default.
• W2018093166 cites W2010638326 @default.
• W2018093166 cites W2011810742 @default.
• W2018093166 cites W2015344488 @default.
• W2018093166 cites W2017041417 @default.
• W2018093166 cites W2021422667 @default.
• W2018093166 cites W2023624246 @default.
• W2018093166 cites W2047145213 @default.
• W2018093166 cites W2048835394 @default.
• W2018093166 cites W2057516761 @default.
• W2018093166 cites W2059073471 @default.
• W2018093166 cites W2061010923 @default.
• W2018093166 cites W2070216704 @default.
• W2018093166 cites W2070590745 @default.
• W2018093166 cites W2073031475 @default.
• W2018093166 cites W2075880922 @default.
• W2018093166 cites W2077129920 @default.
• W2018093166 cites W2083340333 @default.
• W2018093166 cites W2085724817 @default.
• W2018093166 cites W2100542389 @default.
• W2018093166 cites W2102526923 @default.
• W2018093166 cites W2112666278 @default.
• W2018093166 cites W2120121168 @default.
• W2018093166 cites W2127990020 @default.
• W2018093166 cites W2130852323 @default.
• W2018093166 cites W2139354324 @default.
• W2018093166 cites W2141528503 @default.
• W2018093166 cites W2150341008 @default.
• W2018093166 cites W2155191802 @default.
• W2018093166 cites W2156365755 @default.
• W2018093166 cites W2163069245 @default.
• W2018093166 cites W2166005929 @default.
• W2018093166 cites W4322701573 @default.
• W2018093166 doi "https://doi.org/10.1038/labinvest.3700482" @default.
• W2018093166 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17075581" @default.
• W2018093166 hasPublicationYear "2006" @default.
• W2018093166 type Work @default.
• W2018093166 sameAs 2018093166 @default.
• W2018093166 citedByCount "344" @default.
• W2018093166 countsByYear W20180931662012 @default.
• W2018093166 countsByYear W20180931662013 @default.
• W2018093166 countsByYear W20180931662014 @default.
• W2018093166 countsByYear W20180931662015 @default.
• W2018093166 countsByYear W20180931662016 @default.
• W2018093166 countsByYear W20180931662017 @default.
• W2018093166 countsByYear W20180931662018 @default.
• W2018093166 countsByYear W20180931662019 @default.
• W2018093166 countsByYear W20180931662020 @default.
• W2018093166 countsByYear W20180931662021 @default.
• W2018093166 countsByYear W20180931662022 @default.
• W2018093166 countsByYear W20180931662023 @default.
• W2018093166 crossrefType "journal-article" @default.
• W2018093166 hasAuthorship W2018093166A5002545881 @default.
• W2018093166 hasAuthorship W2018093166A5003459453 @default.
• W2018093166 hasAuthorship W2018093166A5015059017 @default.
• W2018093166 hasAuthorship W2018093166A5029653810 @default.
• W2018093166 hasAuthorship W2018093166A5046740518 @default.
• W2018093166 hasAuthorship W2018093166A5060455569 @default.
• W2018093166 hasAuthorship W2018093166A5079838143 @default.
• W2018093166 hasAuthorship W2018093166A5082035709 @default.
• W2018093166 hasAuthorship W2018093166A5084386513 @default.
• W2018093166 hasBestOaLocation W20180931661 @default.
• W2018093166 hasConcept C104317684 @default.
• W2018093166 hasConcept C127561419 @default.
• W2018093166 hasConcept C129470790 @default.
• W2018093166 hasConcept C13373296 @default.

• next